Relmada Therapeutics Inc (RLMD) - מכפיל מחיר להכנסות עתידי

Relmada Therapeutics (RLMD) relies on outsourcing production and testing to maintain R&D flexibility. High barriers to entry are created by REL-1017 patents under strict FDA oversight. The company's fate is tied to the success of trials and the rate of capital expenditure. This forward price-to-sales chart visualizes these trends, and the current metric has reached the level of .
פילוחי מדדים מקיפים ואנליטיקה עבור Relmada Corp (RLMD)

The dynamics of this multiple reflect market expectations regarding future sales and the business's ability to maintain its capitalization amid changing external conditions. Since Relmada Therapeutics (RLMD) is in the clinical trial stage and has no current revenue, the company's forward P/S chart demonstrates a speculative valuation of potential revenue, which currently depends entirely on the efficiency of raising external capital.